Download PDF File

Thirty years at the interface of organic chemistry and biotechnology, and ten years of successful interdisciplinary consultancy serving small/start-up pharma, chemical and industrial biotech companies.  

Provides CTO-level management and patent liaison for operations, and technical due diligence for investment. Extensive experience interacting with academics, staff scientists, patent counsel and business-development in start-ups. 

Directed multi-disciplinary process development groups in major pharmaceutical corporations. Built new, practical technology base within both small company and large corporate environments. Delivered profitable IP, process scale-up, and novel automation. Extensive project management experience covering process chemistry, molecular biology, biotransformations & biocatalysis, plus fermentation of natural products and recombinant enzymes and biobased chemicals. Developed and scaled processes for the biological production of commodity chemicals from biomass, including cost-analyses. Extensive experience under GMP; provided CMC sections of IND & NDA filings. Excellent communication skills; frequently invited to explain technical issues to patent, licensing, regulatory, and business groups, and to serve on due-diligence teams. Expert witness experience. Service as North American Editor of international peer-reviewed journal and as Chairs of international symposia in the field of biocatalysis. United States and Canadian citizenships.

INDEPENDENT CONSULTING; DODDS & ASSOCIATES LLC www.techdiligence.net		2002-
Founded Dodds & Associates to provide strategic technical planning and project management to the pharmaceutical, biotech, and chemical industries. Work with small and start-up companies needing interdisciplinary experience at a CTO-level to establish technical strategy, manage IP, and execute project management. Extensive industrial and academic network. Executed contracts with over two dozen clients since 2002. Client references available. Completed and current projects include:
	Service on technical Advisory Boards; technical presentations to Corporate Boards and investors
	Intellectual property review and strategy, technical assessment and due-diligence
	Project Management:
	-process review, development, and scale-up for both pharma and non-pharma projects including industrial biotechnology -contractor selection, site visits and reporting, technology transfer -drafting CMC sections for IND & NDA, batch record drafting and review for GMP production -develop and run biological/fermentation processes for production of non-fuel commodity chemicals from biomass
	Interim technical executive for small entities:
	-CTO-level management; intellectual property review and competitor technology review, patent liaison -interim CSO for client; responsible for lab build-out, technology base, contract work & staffing -identification of technical opportunities for investment, due-diligence, preparation of white-papers for investment fund, presentations to regional development committees
	Expert witness; experience in depositions and cross-examination
BRISTOL-MYERS SQUIBB CO. , SYRACUSE, NEW YORK DIRECTOR, FERMENTATION & BIOCATALYSIS DEVELOPMENT ASSOCIATE DIRECTOR, ENZYME DEVELOPMENT		1999 - 2001 2000 - 2001 1999 - 2000
Invited to BMS to lead a new group of 50 scientists organized into chemical process development, molecular biology, fermentation development, and GMP analytical functions. Managed $4 million in annual operating and capital budgets. Achieved cost-savings by applying biocatalysis in chemical syntheses and evaluated these with outsourcing group. Developed chiral chemical processes, plus fermentations for natural products, enzyme production, and biocatalysis.
	Solved production problems with enzymatic process experienced by an external supplier. Recovered over 3 tons of in-process material critical to launch supply to meet specifications.
	Developed process to chiral intermediate for HIV therapeutic via biological reduction, allowing significant cost-savings over vendor pricing of tonne quantities.
	Developed natural product fermentation process that gave a three-fold increase in production within 12 months. Re-wrote and updated all documentation necessary for GMP compliance.
	Conceived and managed chemical gene synthesis and expression project to replace bovine enzyme and eliminate TSE/BSE regulatory issues in an existing commercial process.
	Directed submission of six chemical and fermentation process patent applications in 18 months.
	With neither a budget nor formally assigned project, managed preparation of an existing facility - designed for other purposes - for first half of TAXOL